Afuco™ Anti-Human TARDBP ADCC Therapeutic Antibody, ADCC Enhanced
Anti-TARDBP ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The human antibodies specific bind to TDP-43 can be used in therapeutic applications including for example, passive vaccination strategies for treating disorders related to aggregates or other aberrations in TDP-43 expression, such as, frontotemporal lobar degeneration and/or, amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease and other TDP-43 proteinopathies.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-571CL |
| Pricing | Inquiry |
| Host | Human |
| Target | TARDBP |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at -20°C for long-term storage. Store at 4°C for up to one month. Avoid freeze/thaw cycles. |